TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Simulations Plus Inc (SLP)

Healthcare Health Information Services
18.20 $
-0.4% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Simulations Plus Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 4 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
18.30$
Open
18.30$
Day High
18.30$
Day Low
18.20$
Volume
377,739shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
11.40 $ 20.80 $
03/30/2026 01/23/2026

Current price 18.20 $ — 72% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
0.4$B
Shares Outstanding
20Mio.
Float
83.1%
Beta
1.3

Performance

Perf. 1M
10.00%
Perf. 3M
60.90%
Perf. 6M
-4.20%
YTD Performance (%)
-0.40%
52-Week-High Distance
-13.7%
Perf. 1Y
40.02%
Perf. 3Y
-63.17%
Perf. 5Y
-60.70%
Perf. 10Y
145.39%
Perf. Since Inception
1,600.08%

Technical Indicators

MA 38 Days
17.90$
MA 50 Days
17.50$
MA 200 Days
16.20$
RSI (14)
59.3
Volatility 30 Days
5.2%
Volatility 250 Days
49.3%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
52.9
PEG
9.9
P/B
P/S
4.5
EV/EBITDA
18.7
Price/FCF
16.1

Profitability

Gross Margin
63.4%
EBIT Margin
Net Margin
9.9%
Return on Equity
-38.8%
Return on Assets
5.5%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
fortress balance sheet
Altman Z″
16.60
very solid
Piotroski
9 out of 9

Growth

Sales Growth Last Quarter
8.30%
EPS Growth Last Quarter
46.70%
Sales Growth (Year)
13.09%
Forward Sales Growth
5.50%
Forward EPS Growth
4.30%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
3
RS Rating
69
EPS Rating
76
very solid
Piotroski
9 out of 9
Fundamental Rating
C (53 out of 100)
fortress balance sheet
Altman Z″
16.60

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 18.20 $
Price Target (average) 17.25 $

The price target sits 5.2% below the current price.

Consensus
Strong Sell
Analyst Ratings
6
Distribution of Recommendations
Strong Buy 5
Buy 0
Hold 1
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
08/31/2026 0.86 0.80 – 0.93 82 -16.5% 4
08/31/2027 0.88 0.85 – 0.91 86 2.6% 4

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

29. Oct 2026 · after the close · Q3 2026
Expected Earnings per Share
0.16 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 18.9 $M Q4 2025: Q1 · 22.4 $M Q1 2025: Q2 · 20.4 $M Q2 2025: Q3 · 17.5 $M Q3 2025: Q4 · 18.4 $M Q4 2026: Q1 · 24.3 $M Q1 2026: Q2 · 21.9 $M Q2

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.01 -89.40 19 30.50 1.10 -1 -1
2025: Q1 0.15 -23.60 22 22.50 13.70 6 6
2025: Q2 -3.35 -2,280.00 20 9.80 -330.60 8 8
2025: Q3 -0.03 -180.40 18 -6.50 -3.90 6 5
2025: Q4 0.03 228.90 18 -2.70 3.70 4 3
2026: Q1 0.22 47.90 24 8.30 18.70 6 6
2026: Q2 0.18 105.40 22 7.40 16.40 9 9
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 18 6 4 7
2017 24 8 6 0.33 7 26 39
2018 30 10 9 0.50 9 32 44
2019 34 11 9 0.48 12 38 46
2020 42 12 9 0.50 11 156 170
2021 46 11 10 0.47 19 166 182
2022 54 15 12 0.60 18 178 191
2023 60 9 10 0.49 22 170 193
2024 70 6 10 0.49 13 182 208
2025 79 -71 -65 -3.22 18 125 132

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Employees212
HeadquartersResearch Triangle Park, NC
Address800 Park Offices Drive, 27709 Research Triangle Park, United States
Phone661 723 7723
Websitesimulations-plus.com
IPO Date18. Jun 1997
ISINUS8292141053
Stock Split2:1 on 10/02/2007

Management

Management
Name Title Birth Year
Shawn M. O'Connor Chief Executive Officer 1960
William Frederick CFO, Executive VP & Corporate Secretary 1964
Josh Fohey Chief Operating Officer 1983
John Anthony DiBella M.S. Chief Revenue Officer 1980
Jill Fiedler-Kelly M.S. President of Services Solutions 1970
Steven Chang Global Head of Strategic Alliances 1968
Jennifer Presnell Accounting Manager
Viera Lukacova Ph.D. Chief Science Officer 1974
Bud Nelson J.D., Ph.D. VP, Corporate Counsel & Personal Data Protection Officer
Christina Hendrickson Senior Director of Corporate Marketing

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
6. Jul 2026 DiBella John Anthony II Chief Revenue Officer Sell 1,000 18.36 18,360

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?